DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0040761 | Transposition of Great Vessels | PIGL | 9487 | phosphatidylinositol glycan anchor biosynthesis class L | Q9Y2B2 |
C0432333 | Abnormal dermatoglyphic pattern | PIGL | 9487 | phosphatidylinositol glycan anchor biosynthesis class L | Q9Y2B2 |
C0494475 | Tonic - clonic seizures | PIGL | 9487 | phosphatidylinositol glycan anchor biosynthesis class L | Q9Y2B2 |
C0010346 | Crohn Disease | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0038013 | Ankylosing spondylitis | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0006826 | Malignant Neoplasms | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0004238 | Atrial Fibrillation | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0235480 | Paroxysmal atrial fibrillation | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0269102 | Endometrioma | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0029408 | Degenerative polyarthritis | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0014175 | Endometriosis | UST | 10090 | uronyl 2-sulfotransferase | Q9Y2C2 |
C0235974 | Pancreatic carcinoma | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C2239176 | Liver carcinoma | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0346647 | Malignant neoplasm of pancreas | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0023467 | Leukemia, Myelocytic, Acute | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0007102 | Malignant tumor of colon | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0699790 | Colon Carcinoma | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0001418 | Adenocarcinoma | B3GALT5 | 10317 | beta-1,3-galactosyltransferase 5 | Q9Y2C3 |
C0265343 | Jarcho-Levin syndrome | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0036572 | Seizures | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0036439 | Scoliosis, unspecified | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C3714756 | Intellectual Disability | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0025958 | Microcephaly | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0000768 | Congenital Abnormality | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
C0085136 | Central Nervous System Neoplasms | SLC35A3 | 23443 | solute carrier family 35 member A3 | Q9Y2D2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024